Company Filing History:
3 out of 721 
2 out of 378 
Years Active: 2012-2017
Title: Klaus Benke: Innovator in Pharmaceutical Dosage Forms
Introduction
Klaus Benke is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 5 patents, his work has had a considerable impact on medical treatments.
Latest Patents
Klaus Benke's latest patents include a solid pharmaceutical dosage form comprising sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate. This invention focuses on solid forms for oral administration that release the active ingredient effectively. Additionally, he has developed a solid, orally administrable pharmaceutical composition that includes 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide in hydrophilized form, aimed at treating various diseases.
Career Highlights
Throughout his career, Klaus Benke has worked with prominent companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.
Collaborations
Klaus has collaborated with notable colleagues, including Andreas Ohm and Hanna Tinel. These partnerships have contributed to the advancement of his research and development efforts.
Conclusion
Klaus Benke is a distinguished inventor whose work in pharmaceutical dosage forms has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.